Compare PRGO & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRGO | BSTZ |
|---|---|---|
| Founded | 1887 | 2019 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2013 | N/A |
| Metric | PRGO | BSTZ |
|---|---|---|
| Price | $11.27 | $30.28 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $19.33 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 214.7K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 10.28% | 8.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.71 |
| Revenue | ★ $800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.02 | N/A |
| P/E Ratio | ★ N/A | $42.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.23 | $19.13 |
| 52 Week High | $28.44 | $30.46 |
| Indicator | PRGO | BSTZ |
|---|---|---|
| Relative Strength Index (RSI) | 51.54 | 69.83 |
| Support Level | $11.26 | $21.00 |
| Resistance Level | $12.36 | N/A |
| Average True Range (ATR) | 0.46 | 0.77 |
| MACD | 0.02 | 0.11 |
| Stochastic Oscillator | 59.85 | 89.19 |
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.